A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful and sudden onset of swelling, sometimes resulting in death.
Empowering communities: Know Diabetes by Heart initiative awards grants to combat cardiovascular disease
The American Diabetes Association and the American Heart Association have awarded grants to 10 community organizations to help people living with Type 2 diabetes lower
December 11, 2023